Deborah Suchman
Nurse Practitioner · Washington, DCNPI 1972055457
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Pfizer at 26.0% of the total. 2025 is the largest year on record at $489, 3.6 times the $137 reported in 2023.
Across 34 payments — averaging $25.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$221
- Phathom Pharmaceuticals, Inc.$134
- Novo Nordisk$122
- Astellas Pharma US Inc$119
- Exact Sciences$97
- Inspire Medical Systems, Inc.$66
- plus $92 from 3 others
What the payments were for
- Food & beverage$851100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 11 | $221 |
| Phathom Pharmaceuticals, Inc. | 2 | $134 |
| Novo Nordisk | 4 | $122 |
| Astellas Pharma US Inc | 6 | $119 |
| Exact Sciences | 3 | $97 |
| Inspire Medical Systems, Inc. | 3 | $66 |
| Lilly USA, LLC | 2 | $40 |
| Seqirus USA Inc | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOQUEZNA$113
How this compares
$851 in reported general payments places this provider in the 85th percentile of 224 nurse practitioner providers in District of Columbia.
See all nurse practitioner providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 64 | $1,386 |
| Sucralfate | 13 | $1,334 |
| Atorvastatin Calcium | 126 | $1,224 |
| Wixela InhubFluticasone Propion/Salmeterol | 13 | $841 |
| Levothyroxine Sodium | 55 | $823 |
| Metoprolol Succinate | 38 | $598 |
| Lisinopril | 43 | $574 |
| Pravastatin Sodium | 15 | $423 |
| Amlodipine Besylate | 62 | $397 |
| Metformin Hcl ErMetformin Hcl | 16 | $368 |
| Escitalopram Oxalate | 17 | $278 |
| Pantoprazole Sodium | 18 | $180 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $170 |
| Metformin Hcl | 16 | $160 |
| Alprazolam | 11 | $144 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Washington
- Rasheda PersingerWashington$88K
- Caitlin YazelWashington$45K
- Aimee LestrangeWashington$37K
- Guinevere QueWashington$27K
- Cynthia BitherWashington$17K
- Safia AbdillahiWashington$11K
- Brigid ReynoldsWashington$6K
- Odette NtamWashington$5K
- Kathryn HilgartnerWashington$5K
- Mary AlderWashington$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.